Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Jun 6, 2022; 10(16): 5217-5229
Published online Jun 6, 2022. doi: 10.12998/wjcc.v10.i16.5217
Figure 1
Figure 1 Overall survival among male, menstrual female and menopausal female groups.
Figure 2
Figure 2 Overall survival among male, menstrual female and menopausal female groups in subgroups without adjuvant chemotherapy (A) and with adjuvant chemotherapy (B).
Figure 3
Figure 3 Overall survivals among male, menstrual female and menopausal female groups in subgroups with proportion of signet ring cells < 50% (A) and > 50% (B).